ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $53.40 and traded as high as $56.15. ProShares Ultra Nasdaq Biotechnology shares last traded at $55.17, with a volume of 9,601 shares traded.
ProShares Ultra Nasdaq Biotechnology Stock Performance
The stock has a 50 day simple moving average of $53.40 and a two-hundred day simple moving average of $59.59.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
The firm also recently announced a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd were given a $0.3964 dividend. The ex-dividend date of this dividend was Monday, December 23rd. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.
Institutional Investors Weigh In On ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Recommended Stories
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Bank Stocks – Best Bank Stocks to Invest In
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Why Invest in High-Yield Dividend Stocks?
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Want to Profit on the Downtrend? Downtrends, Explained.
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.